IXC
Click for more information
1.52% 6.7¢ invex therapeutics ltd

Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-12

  1. IndexInvestor
    8,391 Posts.
    lightbulb Created with Sketch. 1383
    clock Created with Sketch.
    04/11/21
    09:51
    Post #: 57304403
    Would it be appropriate to ask questions at the presentation about the free shares brainwave?
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

CUV British study shows Clinuvel drug effective on DNA of UV-damaged skin
right-arrow Created with Sketch.
RZI Raiz to exit Malaysia; focus on Australian business growth
right-arrow Created with Sketch.
AWJ Auric jumps 10% on maiden cash sales in Q3CY24 and firm guidance
right-arrow Created with Sketch.
STN Saturn’s stars have aligned for the gold explorer’s Apollo Project
right-arrow Created with Sketch.
CXO Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
right-arrow Created with Sketch.
ITM Fast-track assaying yields 182 g/t gold for iTech at new NT play
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.7¢ 		Change
0.001(1.52%) 		Mkt cap ! $5.035M
Open High Low Value Volume
6.6¢ 6.7¢ 6.6¢ $202 3.026K

Buyers (Bids)

No. Vol. Price($)
1 7739 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 10000 1
View Market Depth
Last trade - 15.59pm 08/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.